The Pasteur Museum is housed in the apartment where Louis Pasteur spent his final seven years and offers a rare behind-the-scenes look at the living and working environment of the world-renowned scientist. Visitors can gain a unique insight into his everyday life alongside his wife and can admire his rich and diverse scientific work.
The Institut Pasteur’s scientific strategy focuses on developing original and innovative topics and promoting interdisciplinary and multidisciplinary cooperation and approaches. The Institut Pasteur teams have access to the technological resources needed to speed up and further improve the quality of their outstanding research.
Ever since the introduction of the world’s first "Technical Microbiology" course in 1889, teaching has been a priority for the Institut Pasteur. The Institut Pasteur has an international reputation for quality teaching that attracts students from all over the world who come to further their training or top up their degree programs.
The mission of the Industrial Partnership team is to detect, promote, assist and protect the inventive activities from research (inventions, know-how and biological materials) conducted at the Institut Pasteur (and in some Institutes of its international network), and transfer there to industrial and/or institutional partners, in order to serve the patient needs and for the benefit of the society, as well as to contribute to sustainability of the Institut Pasteur’s resources.
With international courses, PhD and postdoctoral traineeship, each institute of the Institut Pasteur International Network (RIIP) contributes to the transmission of knowledge with the training of young researchers all around the world. In this context, doctoral and postdoctoral programmes, study and traineeship fellowships are available to scientists. Alongside training, dynamism and attractiveness of RIIP will result in the creation of 4-year group for the young researchers.
Trends of pneumococcal meningitis: unmasking the role of winter viruses and antimicrobial drugs
Abstract: Pneumococcal meningitis is a major cause of morbidity and mortality worldwide resulting in potentially severe relapse. The mechanisms responsible for the epidemiological patterns of susceptible- and resistant-pneumococcal meningitides, which include a yearly winter peak, are poorly understood. In this talk, we investigate potential interactions between pneumococcal meningitis incidence and both acute viral respiratory infections (AVRI) and drug consumption (antibiotics and vaccine). In a first step, French time series of pneumococcal meningitides, AVRI and beta-lactam prescriptions in the pre-vaccine era are analyzed. Mathematical modelling of pneumococcal meningitis dynamics is then used to explore the interaction between meningitis, AVRI and antibiotic exposure: four hypothetical models are developed and their abilities to reproduce the 2001-2004 meningitides dynamics are compared. In a second step, the analysis is extended to the post anti-pneumococcal-vaccine era and hypotheses related to serotypes replacement and strain competition are investigated.